P8IP
IMMU

Pier 88 Investment Partners’s Immunomedics Inc IMMU Stock Holding History

Pier 88 Investment Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-27,023
Closed -$2.3M – 134
2020
Q3 		$2.3M Sell
27,023
-12,791
-32% -$647K 0.7% 33
2020
Q2 		$1.41M Buy
39,814
+1,154
+3% +$33.7K 0.4% 65
2020
Q1 		$521K Buy
38,660
+27,860
+258% +$469K 0.19% 74
2019
Q4 		$229K Buy
+10,800
New +$191K 0.09% 82

Pier 88 Investment Partners's IMMU Position: Q4 2020 in Review

Pier 88 Investment Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 27,023 shares — an estimated $2.3M sold.

Pier 88 Investment Partners first reported a position in IMMU in Q4 2019 and held it in 4 quarters. The position peaked at $2.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Pier 88 Investment Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Pier 88 Investment Partners sold 27,023 Immunomedics Inc shares in Q4 2020, an estimated $2.3M.
  • Pier 88 Investment Partners first reported a position in Immunomedics Inc in Q4 2019 and held it in 4 quarters.
  • Pier 88 Investment Partners's Immunomedics Inc position peaked at $2.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Pier 88 Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.